ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0176

Race-Based Differences in Immune Responses Following an Episode of Acute Low Back Pain Among Those Who Develop Chronic LBP and Those Who Do Not

Colleen Burke1, Michael Brown2, Rebecca Fillipo3, Stephanie Danyluk2, Kelley Seebeck2 and Adam Goode2, 1Duke University School of Medicine, Chapel Hill, NC, 2Duke University, Durham, NC, 3Duke University School of Medicine, Durham, NC

Meeting: ACR Convergence 2024

Keywords: Back pain, immunology, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Acute low back pain (LBP) affects over 25% of adults annually in the United States, and as many as one-third of these individuals will develop chronic LBP. Many disparities in LBP exist, including this transition from acute to chronic LBP, with Black adults experiencing nearly twice the transition rate compared to White adults. Social determinants of health, such as race, are often associated with differences in health status and outcomes, with negative social exposures being associated with heightened systemic inflammation, immune cell activation, and prolonged recovery from health events. The purpose of this study was to examine if race was associated with immunological changes during the transition from acute to chronic LBP.

Methods: Adults experiencing acute LBP (pain < 4 weeks with no pain in the prior 30 days), were recruited from the community. Data was gathered at baseline and 3-month follow-up to determine the participant’s low back pain status (i.e., transition to cLBP). At both study visits, pain questionnaires and blood samples were collected, demographic characteristics were captured at baseline visit only. Peripheral blood mononuclear cell (PBMC) phenotyping and stimulation assays were used to test the differences between innate and adaptive immune status by race and transition status.

Results: Data was collected on 108 adults, of which 98 identified as White or Black/African American (69% white, 21.3% Black or African American), with a mean age of 58.98 years and approximately 60% female. Inflammatory plasma cytokine differences between those who transitioned to chronic LBP and those who did not transition were generally consistent between Black adults and White adults. Notably, the association of a subset of immune cell phenotypes with chronic LBP transition were race specific. Among these included plasma cytokine changes by race and transition status (Figure 1). CD11c on monocytes and CD25 (activation marker) on conventional CD4 T cells. Both markers were higher in those who transitioned to chronic LBP compared to those who did not transition to chronic LBP, but only in Black participants at baseline (Figure 2). Differences between changes in levels of B cells and Monocytes were noted based on transitioning to chronic LBP vs. not transitioning as well as differences by race, with White adults who did not transition having the greatest level of change in both B cells and Monocytes (Figure 2). Additionally, differences in PD-L1 on B cells and monocytes changes were greatest in White adults who do not transition to chronic LBP and lowest in Black adults who do transition to chronic LBP (Figure 3).

Conclusion: Immunological features are associated with race in the transition to chronic LBP. Racial disparities are observed in immunological features associated with the transition to chronic LBP. Changes in inflammatory responses are highest in White adults who do not develop chronic LBP. While race alone does not explain these differences, it points to the need for further investigation into how social factors influence the immune system leading to disparities in LBP outcomes.

Supporting image 1

Figure 1. Plasma cytokine levels at each time point (0 or 3-months) separated by those who did not transition to chronic LBP (NT) and those who transitioned to chronic LBP (T), and separated by race (White vs. Black), normalized to z-scores within each cytokine; asterisks indicate Mann-Whitney test p<0.05 versus acute cohort values at the same time point

Supporting image 2

Figure 2. Percentage of cell positive for the denoted markers (CD11c and CD25+) on monocytes, along with the biological significance of the markers, separated by those who did not transition to chronic LBP (NT) and those who transitioned to chronic LBP (T), and separated by race (White vs. Black).

Supporting image 3

Figure 3. PD-L1 Expression on B-cells and Monocytes separated by those who did not transition to chronic LBP (NT) and those who transitioned to chronic LBP (T) and separated by race (White vs. Black).


Disclosures: C. Burke: None; M. Brown: None; R. Fillipo: None; S. Danyluk: None; K. Seebeck: None; A. Goode: None.

To cite this abstract in AMA style:

Burke C, Brown M, Fillipo R, Danyluk S, Seebeck K, Goode A. Race-Based Differences in Immune Responses Following an Episode of Acute Low Back Pain Among Those Who Develop Chronic LBP and Those Who Do Not [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/race-based-differences-in-immune-responses-following-an-episode-of-acute-low-back-pain-among-those-who-develop-chronic-lbp-and-those-who-do-not/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/race-based-differences-in-immune-responses-following-an-episode-of-acute-low-back-pain-among-those-who-develop-chronic-lbp-and-those-who-do-not/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology